Cargando…
Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study
BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008494/ https://www.ncbi.nlm.nih.gov/pubmed/29716756 http://dx.doi.org/10.1016/j.ijcard.2018.04.061 |
_version_ | 1783333187288563712 |
---|---|
author | Corcoran, David Young, Robin Adlam, David McConnachie, Alex Mangion, Kenneth Ripley, David Cairns, David Brown, Julia Bucciarelli-Ducci, Chiara Baumbach, Andreas Kharbanda, Rajesh Oldroyd, Keith G. McCann, Gerry P. Greenwood, John P. Berry, Colin |
author_facet | Corcoran, David Young, Robin Adlam, David McConnachie, Alex Mangion, Kenneth Ripley, David Cairns, David Brown, Julia Bucciarelli-Ducci, Chiara Baumbach, Andreas Kharbanda, Rajesh Oldroyd, Keith G. McCann, Gerry P. Greenwood, John P. Berry, Colin |
author_sort | Corcoran, David |
collection | PubMed |
description | BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of patients presenting with suspected CAD who had coronary microvascular dysfunction. METHODS: Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease 2 (CE-MARC 2) was a prospective multicenter randomised controlled trial of functional imaging versus guideline-based management in patients with suspected CAD. Invasive coronary angiography was protocol-directed. Fractional flow reserve (FFR) and parameters of microvascular function (coronary flow reserve (CFR), index of microcirculatory resistance (IMR), resistance reserve ratio (RRR)) were measured in major epicardial coronary arteries with ≥40–≤90% diameter stenosis. An FFR value ≤0.80 indicated the presence of obstructive CAD. RESULTS: 267/1202 (22.2%) patients underwent angiography and 81 (30%) patients had FFR measured. 63 (78%) of these patients had microvascular function assessed in 85 arteries (mean age 58.5 ± 8.2 years; 47 (75%) male). 25/63 (40%) patients had NOCAD, and of these, 17 (68%) had an abnormality ≥1 parameter of microvascular function (abnormal IMR (≥25), abnormal CFR (<2.0), and abnormal RRR (<2.0) occurred in 10 (40%), 12 (48%), and 11 (44%), respectively). 38/63 (60%) patients had obstructive epicardial CAD. Of these patients, 15/38 (39%), 20/38 (53%), and 12/38 (32%) had an abnormal IMR, CFR and RRR, respectively. CONCLUSIONS: Coronary microvascular dysfunction is common in patients with angina. Invasive assessment of microvascular function may be informative and relevant for decision-making in patients with both NOCAD and obstructive epicardial CAD. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01664858 |
format | Online Article Text |
id | pubmed-6008494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-60084942018-09-01 Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study Corcoran, David Young, Robin Adlam, David McConnachie, Alex Mangion, Kenneth Ripley, David Cairns, David Brown, Julia Bucciarelli-Ducci, Chiara Baumbach, Andreas Kharbanda, Rajesh Oldroyd, Keith G. McCann, Gerry P. Greenwood, John P. Berry, Colin Int J Cardiol Article BACKGROUND: In patients with angina undergoing invasive management, no obstructive coronary artery disease (NOCAD) is a common finding, and angina may persist following percutaneous coronary intervention (PCI). Coronary microvascular dysfunction may be relevant. We aimed to assess the proportion of patients presenting with suspected CAD who had coronary microvascular dysfunction. METHODS: Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease 2 (CE-MARC 2) was a prospective multicenter randomised controlled trial of functional imaging versus guideline-based management in patients with suspected CAD. Invasive coronary angiography was protocol-directed. Fractional flow reserve (FFR) and parameters of microvascular function (coronary flow reserve (CFR), index of microcirculatory resistance (IMR), resistance reserve ratio (RRR)) were measured in major epicardial coronary arteries with ≥40–≤90% diameter stenosis. An FFR value ≤0.80 indicated the presence of obstructive CAD. RESULTS: 267/1202 (22.2%) patients underwent angiography and 81 (30%) patients had FFR measured. 63 (78%) of these patients had microvascular function assessed in 85 arteries (mean age 58.5 ± 8.2 years; 47 (75%) male). 25/63 (40%) patients had NOCAD, and of these, 17 (68%) had an abnormality ≥1 parameter of microvascular function (abnormal IMR (≥25), abnormal CFR (<2.0), and abnormal RRR (<2.0) occurred in 10 (40%), 12 (48%), and 11 (44%), respectively). 38/63 (60%) patients had obstructive epicardial CAD. Of these patients, 15/38 (39%), 20/38 (53%), and 12/38 (32%) had an abnormal IMR, CFR and RRR, respectively. CONCLUSIONS: Coronary microvascular dysfunction is common in patients with angina. Invasive assessment of microvascular function may be informative and relevant for decision-making in patients with both NOCAD and obstructive epicardial CAD. CLINICAL TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT01664858 Elsevier 2018-09-01 /pmc/articles/PMC6008494/ /pubmed/29716756 http://dx.doi.org/10.1016/j.ijcard.2018.04.061 Text en © 2018 The Authors http://creativecommons.org/licenses/by/4.0/ This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Corcoran, David Young, Robin Adlam, David McConnachie, Alex Mangion, Kenneth Ripley, David Cairns, David Brown, Julia Bucciarelli-Ducci, Chiara Baumbach, Andreas Kharbanda, Rajesh Oldroyd, Keith G. McCann, Gerry P. Greenwood, John P. Berry, Colin Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title | Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title_full | Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title_fullStr | Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title_full_unstemmed | Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title_short | Coronary microvascular dysfunction in patients with stable coronary artery disease: The CE-MARC 2 coronary physiology sub-study |
title_sort | coronary microvascular dysfunction in patients with stable coronary artery disease: the ce-marc 2 coronary physiology sub-study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6008494/ https://www.ncbi.nlm.nih.gov/pubmed/29716756 http://dx.doi.org/10.1016/j.ijcard.2018.04.061 |
work_keys_str_mv | AT corcorandavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT youngrobin coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT adlamdavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT mcconnachiealex coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT mangionkenneth coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT ripleydavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT cairnsdavid coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT brownjulia coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT bucciarelliduccichiara coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT baumbachandreas coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT kharbandarajesh coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT oldroydkeithg coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT mccanngerryp coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT greenwoodjohnp coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy AT berrycolin coronarymicrovasculardysfunctioninpatientswithstablecoronaryarterydiseasethecemarc2coronaryphysiologysubstudy |